Skip to content

A Longitudinal Prospective Outcomes Study of Laparoscopic Abdominal Wall Hernia Repair Using Symbotex™ Composite Mesh

A Longitudinal Prospective Outcomes Study of Laparoscopic Abdominal Wall Hernia Repair Using Symbotex™ Composite Mesh

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02341430
Enrollment
50
Registered
2015-01-19
Start date
2016-01-31
Completion date
2018-12-31
Last updated
2019-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Grade II Ventral Hernia, Grade I Ventral Hernia

Keywords

hernia, synthetic mesh

Brief summary

This study is being done to test the efficacy of Symbotex™ as an effective synthetic mesh option in the repair of grade I and II ventral hernias.

Detailed description

This study is being done to validate the efficacy of Symbotex™ as an effective synthetic mesh option in the repair of grade I and II ventral hernias. It will also set the groundwork for a future clinical trial in which the efficacy of Symbotex® can be compared to other synthetic mesh products on the market.

Interventions

DEVICESymbotex™ Composite Mesh

Repair of a Grade I or II ventral hernia according to VHWG classification system with Symbotex™ Composite Mesh

Sponsors

Medtronic - MITG
CollaboratorINDUSTRY
Anne Arundel Health System Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or older * Grade I or II ventral hernia according to VHWG classification system * Pre-operative informed consent is obtainable

Exclusion criteria

* Not candidate for laparoscopic approach for repair of their hernia * Determination in the operating room that biologic mesh is needed over permanent mesh * Fascial defect less than 3 cm in greatest dimension * Concurrent placement of another mesh (synthetic or biologic ) at the site where the study mesh is placed * Grade III or IV ventral hernia according to VHWG system * ASA score IV or above * Any disease or condition along with the surgeon's clinical judgment that contraindicates the use of study mesh. These include but are not limited to the presence of chronically infected tissues subjecting patient to risk of synthetic mesh infection, accidental bowel injury during surgery or anatomy of the patient that is not receptive to laparoscopic surgery or mesh implantation. * Pregnancy * Use of more than one of the same study mesh is not an exclusion criterion in and of itself, so long as the type of mesh is selected according to the randomization protocol. In other words, if the hernia defect is larger than the largest Symbotex™ mesh available, two or more Symbotex mesh pieces may be used to appropriately repair the hernia defect.

Design outcomes

Primary

MeasureTime frame
Hernia RecurrenceOne year
Quality of LifeOne year
Hernia associated pain and movement limitations pre-surgery compared to post-surgeryOne year
Reoperation RateOne year
Percutaneous Intervention RateOne year
Number of Participants with Adverse Events as a Measure of Safety and TolerabilityOne year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026